Latest Market Developments News

Iluka Resources posted a solid 2024 performance with stable market conditions and sound margins despite inflationary pressures, while progressing key projects like Balranald and Eneabba.

Regal Asian Investments has raised its semi-annual dividend target from 5 to 6 cents per share, supported by a robust profits reserve, signaling confidence in sustained shareholder returns.

Charter Hall Long WALE REIT has reversed last year’s heavy losses, reporting a statutory profit of $51.3 million for the half year ended December 2024, while maintaining steady distributions to investors.

Merino & Co’s successful IPO has injected $6.35 million into the company, enabling a strategic expansion of manufacturing capacity and securing a new facility in Western Australia. The company is now poised to scale globally with automated production and enhanced distribution capabilities.

Charter Hall Wholesale Management Limited has extended its off-market takeover offer for Hotel Property Investments, pushing the closing date to March 14, 2025. The offer is now unconditional, having cleared all defeating conditions.

Site Group International edges closer to securing a pivotal Higher Training Institute license in Saudi Arabia, while reporting a robust 112% revenue surge and completing a $1 million capital raise to fuel expansion.

Electro Optic Systems (EOS) has completed the divestment of its EM Solutions subsidiary for $158.6 million, wiping out all borrowings and positioning itself with a strong cash balance of approximately $128 million. The company is actively pursuing significant defence contracts and expanding its manufacturing footprint.

Visioneering Technologies reported a mixed Q4 FY'24 with a slight revenue decline but stronger cash flow and expanding global footprint, underpinned by promising clinical trial data.

Berkeley Energia reports promising lithium and rubidium mineralisation at its Conchas Project while advancing a $1 billion arbitration claim against Spain over regulatory setbacks at Salamanca.

Percheron Therapeutics has terminated its phase IIb avicursen trial for Duchenne muscular dystrophy after failing to meet efficacy endpoints, while securing $14.85 million in fresh capital to explore new therapeutic opportunities.

SportsHero Limited has inked a five-year partnership with Indonesia's Indosat Ooredoo Hutchison to market its Family Game Room product, alongside securing a $1 million debt facility to support its expansion plans.

Radiopharm Theranostics has secured key ethics approvals to expand its clinical trial portfolio, completed significant preclinical milestones, and raised A$8 million through a strategic placement, while maintaining its cash runway to mid-2026.